Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Castle

Showing results (181-190 of 263) with videos related to

Pageof 27
Sort By:
Journal of Psychiatric Research|May 23, 2022
Age of onset by sex in schizophrenia: Proximal and distal characteristicsAjit Selvendra, Wei Lin Toh, Erica Neill, et al.
Australian Health Review : a Publication of the Australian Hospital Association|December 12, 2017
Evaluation of an integrated housing and recovery model for people with severe and persistent mental illnesses: the Doorway programDavid R Dunt, Andrew W Benoy, Andrea Phillipou, et al.
Annals of Emergency Medicine|September 18, 2012
Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trialEsther W Chan, David M Taylor, Jonathan C Knott, et al.
Schizophrenia Bulletin|May 7, 2016
Awareness of Pre-diabetes or Diabetes and Associated Factors in People With PsychosisDebra L Foley, Andrew Mackinnon, Vera A Morgan, et al.
Frontiers in Psychiatry|January 9, 2019
Reducing Smoking Among People With Schizophrenia: Perspectives on Priorities for Advancing ResearchAmanda L Baker, Debbie Robson, Sharon Lawn, et al.
BMC Endocrine Disorders|May 9, 2021
Bridging the gap between diabetes care and mental health: perspectives of the Mental health IN DiabeteS Optimal Health Program (MINDS OHP)Lucienne Ferrier, Chantal F Ski, Casey O'Brien, et al.
Journal of Clinical Psychopharmacology|October 4, 2022
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence GapNicole Ledwos, Joshua D Rosenblat, Daniel M Blumberger, et al.
Social Psychiatry and Psychiatric Epidemiology|September 29, 2009
Body dysmorphic disorder, social anxiety and depressive symptoms in Chinese medical studentsYanhui Liao, Natalie P Knoesen, Yunlong Deng, et al.
International Journal of Mental Health Nursing|October 5, 2023
What accounts for turnover intention in the Australian public mental health workforce?Darren Haywood, Kaitlyn M Crocker, Inge Gnatt, et al.
The American Journal of Drug and Alcohol Abuse|October 25, 2022
A systematic review of gender-responsive and integrated substance use disorder treatment programs for women with co-occurring disordersSamantha Johnstone, Gil Angela Dela Cruz, Natalie Kalb, et al.
Pageof 27

Showing results (181-190 of 263) with videos related to

Sort By:
Pageof 27
Journal of Psychiatric Research|May 23, 2022
Age of onset by sex in schizophrenia: Proximal and distal characteristicsAjit Selvendra, Wei Lin Toh, Erica Neill, et al.
Australian Health Review : a Publication of the Australian Hospital Association|December 12, 2017
Evaluation of an integrated housing and recovery model for people with severe and persistent mental illnesses: the Doorway programDavid R Dunt, Andrew W Benoy, Andrea Phillipou, et al.
Annals of Emergency Medicine|September 18, 2012
Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trialEsther W Chan, David M Taylor, Jonathan C Knott, et al.
Schizophrenia Bulletin|May 7, 2016
Awareness of Pre-diabetes or Diabetes and Associated Factors in People With PsychosisDebra L Foley, Andrew Mackinnon, Vera A Morgan, et al.
Frontiers in Psychiatry|January 9, 2019
Reducing Smoking Among People With Schizophrenia: Perspectives on Priorities for Advancing ResearchAmanda L Baker, Debbie Robson, Sharon Lawn, et al.
BMC Endocrine Disorders|May 9, 2021
Bridging the gap between diabetes care and mental health: perspectives of the Mental health IN DiabeteS Optimal Health Program (MINDS OHP)Lucienne Ferrier, Chantal F Ski, Casey O'Brien, et al.
Journal of Clinical Psychopharmacology|October 4, 2022
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence GapNicole Ledwos, Joshua D Rosenblat, Daniel M Blumberger, et al.
Social Psychiatry and Psychiatric Epidemiology|September 29, 2009
Body dysmorphic disorder, social anxiety and depressive symptoms in Chinese medical studentsYanhui Liao, Natalie P Knoesen, Yunlong Deng, et al.
International Journal of Mental Health Nursing|October 5, 2023
What accounts for turnover intention in the Australian public mental health workforce?Darren Haywood, Kaitlyn M Crocker, Inge Gnatt, et al.
The American Journal of Drug and Alcohol Abuse|October 25, 2022
A systematic review of gender-responsive and integrated substance use disorder treatment programs for women with co-occurring disordersSamantha Johnstone, Gil Angela Dela Cruz, Natalie Kalb, et al.
Pageof 27